Charles Schwab’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-265,763
| Closed | -$12.3M | – | 3688 |
|
|
2023
Q2 | $12.3M | Buy |
265,763
+10,211
| +4% | +$474K | ﹤0.01% | 1810 |
|
|
2023
Q1 | $7.32M | Buy |
255,552
+2,275
| +0.9% | +$65.2K | ﹤0.01% | 2020 |
|
|
2022
Q4 | $7.9M | Buy |
253,277
+64,601
| +34% | +$2.02M | ﹤0.01% | 1984 |
|
|
2022
Q3 | $3.83M | Buy |
188,676
+64,871
| +52% | +$1.32M | ﹤0.01% | 2358 |
|
|
2022
Q2 | $1.92M | Buy |
123,805
+28,724
| +30% | +$446K | ﹤0.01% | 2574 |
|
|
2022
Q1 | $1.82M | Buy |
95,081
+2,937
| +3% | +$56.2K | ﹤0.01% | 2676 |
|
|
2021
Q4 | $2.33M | Buy |
+92,144
| New | +$2.33M | ﹤0.01% | 2648 |
|